A Multifunctional Polymeric Modulator Targeting Autophagic Lipid Efflux for Efficient Atherosclerosis Therapy
ACS Applied Bio Materials · 03.08.2026 · 9 (15) · 7114-7129
DOI: 10.1021/acsabm.6c00847 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 20.07.2026. Verfasst von Tengfei Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao266003, China. Hauptthemen laut MEDLINE: Atherosclerosis, Biocompatible Materials, Curcumin. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Youth Science Foundation, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Impaired lipid metabolism and persistent accumulation of inflammatory macrophages represent major obstacles to effective anti-atherosclerotic (AS) therapy. To overcome the inherent limitations of conventional oral agents and nanocarrier-based systems, we developed a macrophage-targeted modulator by integrating curcumin (Cur) with gold nanoparticles (AuNPs). This construct was designed to concurrently correct dysregulated lipid homeostasis and suppress the expansion of pro-inflammatory macrophage populations. Specifically, protoporphyrin (Por) as a π-conjugated moiety was conjugated to polycaprolactone (PCL) via reactive oxygen species (ROS)-cleavable thioketal (TK) linkers, while AuNPs were functionalized onto hyaluronic acid (HA) backbones (HAPPT) to enable CD44-mediated foam cell recognition. Through self-assembly, Cur was efficiently loaded into the nano-system to yield the final modulator, Cur@HAPPT. Upon cellular uptake, Cur@HAPPT not only drove M1-to-M2 phenotypic repolarization but also provoked robust autophagic activation, collectively contributing to inflammation resolution. The autophagy-triggered cascade further facilitated lipid efflux and constrained inflammatory macrophage expansion, thereby producing a synergistic therapeutic benefit. Overall, Cur@HAPPT effectively attenuated AS progression and reinforced plaque stability, positioning this polymeric modulator as a promising targeted intervention for AS management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao266003, China.
- Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao266073, China.
- Department of Thoracic Surgery, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao266000, China.
- School of Materials Science and Chemical Engineering, Ningbo University, Ningbo315211, China.
- National Engineering Research Center for Biomaterials, Sichuan University, Chengdu610064, China.
Förderung
- National Youth Science Foundation
- Natural Science Foundation of Shandong Province
Zitieren
APA
Yu, T., Yu, D., Xu, P., Yang, Z., Xu, L., He, B., Sun, Y., Liang, Y., & Wang, S. (2026). A Multifunctional Polymeric Modulator Targeting Autophagic Lipid Efflux for Efficient Atherosclerosis Therapy. ACS Applied Bio Materials, 9(15), 7114-7129. https://doi.org/10.1021/acsabm.6c00847
Vancouver
Yu T, Yu D, Xu P, Yang Z, Xu L, He B, et al. A Multifunctional Polymeric Modulator Targeting Autophagic Lipid Efflux for Efficient Atherosclerosis Therapy. ACS Applied Bio Materials. 2026;9(15):7114-7129. doi:10.1021/acsabm.6c00847
BibTeX
@article{Yu2026,
author = {Yu, Tengfei and Yu, Dahai and Xu, Ping and Yang, Zhiyong and Xu, Long and He, Bin and Sun, Yong and Liang, Yan and Wang, Shujie},
title = {A Multifunctional Polymeric Modulator Targeting Autophagic Lipid Efflux for Efficient Atherosclerosis Therapy},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {15},
pages = {7114--7129},
doi = {10.1021/acsabm.6c00847}
}
EUVIMED